Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Functional Status-Based Pain Assessment Tool

Margaret Guy, MD, Rehan Qayyum, MD, Pamela Derby, RN, FNP-BC, Nicole Carter, RN, MSN, NP-C, Jessica Keiser, MD, Alexandra Ulbing, BS, Daniel Sop, BS,MS, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 416.

https://doi.org/10.1182/blood-2019-131315

Published: 2019

Journal Articles

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD

Blood (2019) 134 (Supplement_1): 4912.

https://doi.org/10.1182/blood-2019-124740

Published: 2019

Journal Articles

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Shveta Gupta, MBBS, Ayesha Zia, MD, Ravindra Sarode, MD

Blood (2019) 134 (Supplement_1): 4976.

https://doi.org/10.1182/blood-2019-129118

Published: 2019

Journal Articles

Curriculum in Chronic Lymphocytic Leukemia Narrows the Educational Gaps of the Oncology Healthcare Team

Lauren Willis, PharmD, Lisa Brauer, PhD, Emily S Van Laar, MS, Patrick Kugel, MBA, Katie S Lucero, PhD MS, BS, John N. Allan, MD, Farrukh T. Awan, MD, Danielle M. Brander, MD, Jonathon B. Cohen, MDMS, Jacqueline C Barrientos, MD

Blood (2019) 134 (Supplement_1): 5878.

https://doi.org/10.1182/blood-2019-124808

Published: 2019

Journal Articles

Education and Promotion of MRD Testing within the Multidisciplinary Cancer Care Team for Adults with Acute Lymphoblastic Leukemia in the Community Setting

Monique D. Dawkins, EdD, Firas El Chaer, MD, Leigh Boehmer, PharmD, Ashkan Emadi, MD, Elias Jabbour, MD, Jeffrey Kendall, PsyD, Barbara B. Rogers, CRNP, MN, AOCN, ANP-BC, Sandra Kurtin, PhD, ANP-C, AOCN, Mohamed Hersi, PharmD, Meredith Barnhart, LCSW-R

Blood (2019) 134 (Supplement_1): 5834.

https://doi.org/10.1182/blood-2019-123461

Published: 2019

Journal Articles

Logistical Considerations Related to Melphalan As a Conditioning Agent in Autologous Stem Cell Transplant for Multiple Myeloma: Results of a Survey of Oncology Pharmacists, Nurses and Pharmacy Technicians

Mark Acosta, PharmD, Arrash Darban, PharmD, MS, Matthew Gitlin, PharmD

Blood (2019) 134 (Supplement_1): 5869.

https://doi.org/10.1182/blood-2019-124990

Published: 2019

Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD

Blood (2019) 134 (Supplement_1): 2152.

https://doi.org/10.1182/blood-2019-129858

Published: 2019

Journal Articles

Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study

Jeffrey Baron, PharmD, Christina L. Lombardi, PharmD, Han Yu, PhD, Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Swapna Thota, MD, Eunice S. Wang, MD

Blood (2019) 134 (Supplement_1): 3501.

https://doi.org/10.1182/blood-2019-131629

Published: 2019

Journal Articles

Change in Admission Rates Among Patients Presenting to Emergency Departments with VTE and Low Risk of Complications: A Retrospective Cohort Study from 11 Community Hospitals

William Rhoades, DO, Rasha Khatib, PhD, Kara Nitti, MPH, Marc McDowell, PharmD, BCPS, Rick Szymialis, RPh, Christopher Blair, MS, BA, CCRP

Blood (2019) 134 (Supplement_1): 4694.

https://doi.org/10.1182/blood-2019-126844

Published: 2019

Journal Articles

Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic Impact

Radhika Jhaveri, PharmD, Vaishali Sanchorawala, MD, John Mark Sloan, MD, Adam Lerner, MD, Shayna Sarosiek, Bhavesh Shah, RPh

Blood (2019) 134 (Supplement_1): 4758.

https://doi.org/10.1182/blood-2019-128992

Published: 2019

Journal Articles

An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service

Helen Cashman, MBBS, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, John Moore, MDFRACP,FRCPA, Sam Milliken, MBBS, FRACP, FRCPA, Orly Lavee, MD, Barbara Withers, Eleni Mayson, FRACP, FRCPA, MBBS, MPhil, David Kliman, MBBS, Janet Kesby, Jenny Bell, Sue Vachalec

Blood (2019) 134 (Supplement_1): 4709.

https://doi.org/10.1182/blood-2019-127796

Published: 2019

Journal Articles

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MDMS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 712.

https://doi.org/10.1182/blood-2018-99-110029

Published: 2018

Journal Articles

Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice

Craig W. Freyer, PharmD, Alex Ganetsky, PharmD, Mitchell E. Hughes, PharmD, Tracy M. Krause, PharmD, Colleen Timlin, PharmD, Noelle V. Frey, MD, Elizabeth O. Hexner, MD MS, Alison W. Loren, MD MS, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Alexander E. Perl, MD, David L. Porter, MD, Selina Luger, MD

Blood (2018) 132 (Supplement 1): 4023.

https://doi.org/10.1182/blood-2018-99-112604

Published: 2018

Journal Articles

Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD, MPH, PhD, Scott Wirth, PharmD, Damiano Rondelli, MD, Pritesh Patel, MD

Blood (2018) 132 (Supplement 1): 3542.

https://doi.org/10.1182/blood-2018-99-117657

Published: 2018

Journal Articles

Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 Study

Anne Calleja, Sandra De Barros, Camille Vinson, PharmD, Caroline Protin, MD, Lucie Oberic, MD, Fanny Gallais, Melanie White-koning, Etienne Chatelut, Christian Recher, MD PhD, Sarah Cadot, PhD, Anne Quillet Mary, PhD, Loic Ysebaert, MD PhD, Fabien Despas, PharmD, PhD

Blood (2018) 132 (Supplement 1): 3960.

https://doi.org/10.1182/blood-2018-99-116532

Published: 2018

Journal Articles

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Daniel R Reed, MD, Katie E Ruefer, RN, Tanya D Thomas, RN, Erin L Harr, RN, Elizabeth R Daniels, RN, Jeremy M Sen, PharmD, BCOP, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2018-99-112598

Published: 2018

Journal Articles

Retrospective Evaluation of Pharmacist Assisted Total-Dose Iron Sucrose Protocol in Patients with Iron Deficiency Anemia

Geoff Wall, Pharm.D., FCCP, BCPS, Vedica Sharma, MD, Robert Schneider, MD, Matthew Taylor, DO, Kristi Adams, Pharm.D., BCPS, Gasperi Lindy, Pharm.D., BCPS, Joshua C. Lukenbill, DO

Blood (2018) 132 (Supplement 1): 5824.

https://doi.org/10.1182/blood-2018-99-109788

Published: 2018

Journal Articles

Tackling Cancer Associated Thrombosis: A Multi-Professional Approach

Sumantha Gabriel, BPharm, Kate Musgrave, BA, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 4691.

https://doi.org/10.1182/blood-2018-99-112538

Published: 2018

Journal Articles

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Shen Li, MD, Allaa Ali, MPH, Alexander Lawandi, MD BS, BA, MSc, Myriam Fernandez, RN, Caroline Rousseau, PhD, Doneal Thomas, M.Phil, M.Sc, Sarit Assouline, Chantal Cassis, MD, Todd Campbell Lee, MD MPH, Kelly L. Davison, MD PhD

Blood (2018) 132 (Supplement 1): 2256.

https://doi.org/10.1182/blood-2018-99-119079

Published: 2018

Journal Articles

Real-Word Clinical Management of Patients Treated with Idelalisib in France: A Study of 529 Cases of Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL)

Anne-Sophie Michallet, MD PhD, Emmanuel Gyan, MD PhD, Pierre Feugier, Ana Nunes, PharmD, Tarek Abdelhadi, Loic Ysebaert, MD PhD, Stéphane Leprêtre, MD

Blood (2018) 132 (Supplement 1): 2302.

https://doi.org/10.1182/blood-2018-99-113476

Published: 2018

NARROW

Development and Validation of a Functional Status-Based Pain Assessment Tool

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Curriculum in Chronic Lymphocytic Leukemia Narrows the Educational Gaps of the Oncology Healthcare Team

Education and Promotion of MRD Testing within the Multidisciplinary Cancer Care Team for Adults with Acute Lymphoblastic Leukemia in the Community Setting

Logistical Considerations Related to Melphalan As a Conditioning Agent in Autologous Stem Cell Transplant for Multiple Myeloma: Results of a Survey of Oncology Pharmacists, Nurses and Pharmacy Technicians

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study

Change in Admission Rates Among Patients Presenting to Emergency Departments with VTE and Low Risk of Complications: A Retrospective Cohort Study from 11 Community Hospitals

Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic Impact

An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice

Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays

Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 Study

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Retrospective Evaluation of Pharmacist Assisted Total-Dose Iron Sucrose Protocol in Patients with Iron Deficiency Anemia

Tackling Cancer Associated Thrombosis: A Multi-Professional Approach

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Real-Word Clinical Management of Patients Treated with Idelalisib in France: A Study of 529 Cases of Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only